↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "WFRF:(Albertsen P. C.) "

Sökning: WFRF:(Albertsen P. C.)

Resultat 1-4 av 4

Sortera/gruppera träfflistan

Sortering: Träffar per sida:

Numrering	Referens	Omslagsbild	Hitta
1.	Neal, DE, et al. (författare) Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received 2020 Ingår i: European urology. - : Elsevier BV. - 1873-7560 .- 0302-2838. ; 77:3, s. 320-330 Tidskriftsartikel (refereegranskat)
2.	Turner, EL, et al. (författare) Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee 2016 Ingår i: British journal of cancer. - : Springer Science and Business Media LLC. - 1532-1827 .- 0007-0920. ; 115:1, s. 90-94 Tidskriftsartikel (refereegranskat)
3.	Albertsen, P. C., et al. (författare) Opportunistic prostate-specific antigen testing in Norwegian men: a public health challenge 2024 Ingår i: Bju International. - 1464-4096. ; 133:1, s. 104-111 Tidskriftsartikel (refereegranskat)abstract Objective To describe age-specific prostate-specific antigen (PSA) distributions and resulting prostate cancer diagnoses that arise from population-wide opportunistic PSA testing.Patients and Methods Over 8 million PSA tests were performed on >1.4 million Norwegian men from 2000 to 2020. During this period 43 486 men were diagnosed with localised prostate cancer. Most of the PSA testing reflected opportunistic testing. Age-specific PSA value distributions were constructed for men aged 45-75 years with and without prostate cancer.Results The distributions of PSA values in men with and without prostate cancer widened with age and overlapped extensively from 3 to 7 ng/mL. Localised prostate cancer diagnoses increased 10-fold from the age of 45 to 75 years. PSA testing identified intermediate- or high-grade cancers in 21% (95% confidence interval [CI] 19-23%) of men aged 50-54 years and 42% (95% CI 41-43%) of men aged 70-74 years. Grade group (GG)1, GG2, GG3 and >= GG4 constituted 49%, 31%, 10% and 10% of cancers identified at age 50-54 years and 26%, 26%, 18%, and 30% of cancers identified at age 70-74 years.Conclusion Opportunistic PSA testing increases with ageing and often generates values that cannot discriminate benign prostate enlargement from prostate cancer. A clinical cascade using additional imaging or serum tests is necessary to avoid negative biopsies and the overdiagnosis of indolent disease. The declining specificity of PSA testing with ageing poses a significant public health challenge especially among older men aged >= 70 years.
4.	Martin, RM, et al. (författare) Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial 2024 Ingår i: JAMA. - 1538-3598. ; 331:17, s. 1460-1470 Tidskriftsartikel (refereegranskat)

Skapa referenser, mejla, bekava och länka

Länka till träfflistan

Resultat 1-4 av 4

Avgränsa träffmängd

Typ av publikation: tidskriftsartikel (4)

Typ av innehåll: refereegranskat (4)

Författare/redaktör: Adolfsson, J. (3); Baum, M (2); Ben-Shlomo, Y. (2); Hill, E. (1); Slater, M. (1); Williams, S. (1); visa fler...; Wilson, A. (1); Harvey, A. (1); Baker, S. (1); Smith, D. (1); Robinson, M. (1); Conway, J. (1); Moore, R. (1); Wilson, P. (1); Martin, A. (1); Wills, L. (1); Jones, A. (1); Grant, A. (1); Gray, C. (1); Williams, L. (1); Dixon, N. (1); Bhattarai, S (1); Hart, L. (1); Marshall, F. (1); Davies, C (1); HUGHES, L (1); Wilkinson, J. (1); Smith, L (1); Cooper, D (1); Griffiths, D (1); Rees, M (1); Graham, J. (1); Moore, S. (1); Thompson, P. (1); Toole, J. (1); Paul, A (1); Harris, B (1); McNeill, A (1); Robinson, A (1); Thomas, A (1); Moore, A (1); Smith, GD (1); Harrison, S (1); Roberts, T (1); Williams, A (1); Evans, S. (1); Muller, S. (1); Howard, G (1); Jones, L (1); Fernando, M. (1); visa färre...

Lärosäte: Karolinska Institutet (3); Göteborgs universitet (1)

Språk: Engelska (4)

Forskningsämne (UKÄ/SCB): Medicin och hälsovetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - Nationella bibliotekssystem
LIBRIS.kb.se

pil uppåt

Stäng

Kopiera och spara länken för att återkomma till aktuell vy